Athira Pharma, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
ATHA on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
18706 North Creek Parkway, Suite 104, Bothell, WA

Insiders trading volume in the past year

Athira Pharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Perceptive Advisors Llc Director, 10%+ Owner $12.9M Dec 27, 2023
Mark James Litton President and CEO, Director $269K -$17K -5.93% Dec 31, 2024
Hans Moebius Chief Medical Officer $266K Jan 4, 2024
Kelly A. Romano Director $195K +$100K +105% Jun 21, 2024
Kevin Church Chief Scientific Officer $115K -$6.21K -5.14% Dec 31, 2024
Mark Worthington General Counsel and CCO $88.6K -$6.21K -6.55% Dec 31, 2024
Javier San Chief Medical Officer $72.6K -$6.08K -7.73% Dec 31, 2024
Robert Renninger VP of Finance $64.3K -$1.62K -2.46% Dec 31, 2024
Andrew Gengos CFO and Chief Business Officer $55.2K -$720 -1.29% Sep 3, 2024
Rachel Lenington COO and CDO $11.8K -$1.43K -10.8% Sep 3, 2024
Tadataka Yamada Director May 28, 2021
Grant Pickering Director May 24, 2024
Joseph Edelman Director May 24, 2024
Glenna Mileson Chief Financial Officer Jan 19, 2023
Michael A. Panzara Director May 24, 2024
Barbara Kosacz Director May 24, 2024
John M. Fluke Jr Director May 24, 2024
James A. Johnson Director May 24, 2024

Recent Insider Transactions by Companies or Individuals for Athira Pharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.